Share
Plus: a symposium recap on making cell and gene therapies accessible to everyone
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Boston Medical Center logo

Read in browser

November 9, 2026

Standard JPG-261019_EQTY Research Symposium_Day of Selects-06.jpg

What Makes a Medical Breakthrough? Symposium Addresses How Cell and Gene Therapies Can Reach Everyone 

At BMC Health System's Inclusive Research Symposium, clinicians, scientists, industry leaders, and patient advocates came together around a shared goal: designing access, trust, and community partnership into cell and gene therapies from the very first decision.




Read a recap of the event here →

BMC Study Links Historic Redlining to Higher Opioid Overdose Death Rates in Lower Graded Massachusetts Neighborhoods

OverdoseAwarenessDay_Email.jpg

A new study led by Avik Chatterjee, MD, MPH, addiction specialist at BMC, found that Massachusetts neighborhoods given the lowest grades on historic redlining maps had 86% higher annual opioid-related overdose death rates than those given the highest grades.

Learn more about the findings →

Researcher Spotlight

Alison-Galbraith_435_2x3.jpg

Name: Alison Galbraith, MD, MPH 

Department: Pediatric Primary Care 
Research Focus: I study how the way health insurance is designed, especially Medicaid, affects the ability of children and families to get the care they need. 

Why BMC: I wanted to be in a mission-driven place. As a researcher, I think it is really easy to do research just for the sake of doing research or for your career, but BMC researchers are doing research to really solve problems for our patients.  

Favorite book: "Demon Copperhead" by Barbara Kingsolver 

Find out more here →

Selected Research Publications

  • Bradley, T., Feeney, M., Law, A. C., Peterkin, A. F., Fantasia, K. L., Walkey, A. J., & Bosch, N. A. (2026). Comparative Effectiveness of Phenobarbital vs Diazepam for Alcohol Withdrawal Syndrome. JAMA Internal Medicine.

  • Momper, J. D., Wang, J., Bradford, S., Mustich, I., Johnston, B., Whitson, K., O'Brien, M., Goldberg, E., Yin, D. E., Townley, E., Colsh, K., DeYampert, T., Beijer-Spell, C., Wittawatmongkol, O., Aziz, M., Naidoo, M., Ruenglerdpong, S., Bekker, A., Deville, J. G., Cruz, M. L. S., … IMPAACT 2023 Study Team (2026). Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study. The Lancet HIV.

  • Sharon, S., Qureshi, M. M., Keohan, S., Luk, S., Jang, S., & Truong, M. T. (2026). CyberKnife Stereotactic Body Radiotherapy for Reirradiation of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Outcomes and Prognostic Factors. Head & Neck.

  • Singh, U. B., DiBona, K., Shaikh, S., Mattoo, S. K., Rao, R., Rajan, S., Kumar, N., Karoly, M., Chaudhary, A., & Sinha, P. (2026). Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort. Clinical Infectious Diseases.

  • Solomon, M., Vaidya, A., Waikar, S. S., & Verma, A. (2026). Joint Impact of Aldosterone and Low-Density Lipoprotein Cholesterol on Cardiovascular Risk in CKD. American Journal of Kidney Diseases.

  • Verma, A., Schmidt, I. M., Claudel, S. E., & Waikar, S. S. (2026). Prediction Utility of Urinary Albumin-Creatinine vs Protein-Creatinine Ratios in Chronic Kidney Disease. JAMA.

Connect With Us


Email Marketing by ActiveCampaign